Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Molecular and Cellular Pathology
  • Published:

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

Abstract

The members of MAGE gene family are highly expressed in human hepatocellular carcinoma (HCC). In the present study, we tested the tumour-specific MAGE-1 and MAGE-3 transcripts in the peripheral blood of HCC patients by nested RT–PCR to detect the circulating tumour cells and evaluate their potential clinical implication. Of 30 HCC patients, the positive rate of MAGE-1 and MAGE-3 transcripts was 43.3% (13 out of 30) and 33.3% (10 out of 30) in PBMC samples, whilst the positive rate was 70% (21 out of 30) and 53.3% (16 out of 30) in the resected HCC tissue samples, respectively. The positivity for at least one MAGE gene transcript was 63.3% (19 out of 30) in PBMC samples of HCC patients and 83.3% (25 out of 30) in the resected HCC tissue samples. MAGE-1 and/or MAGE-3 mRNA were not detected in the PBMC of those patients from whom the resected HCC tissues were MAGE-1 or MAGE-3 mRNA negative, nor in the 25 PBMC samples from healthy donors. The detection of MAGE transcripts in PBMC was correlated with the advanced stages and tumour size of the HCC, being 82.4% (14 out of 17) in tumour stages III and IVa, 56.6% (five out of nine) in stage II, and null (nought out of four) in stage I. The serum α-FP in 33.3% (10 out of 30) of HCC patients was normal or slightly elevated (<40 ng ml−1). However, six of these 10 patients (α-FP <40 ng ml−1) were MAGE-1 and /or MAGE-3 mRNA positive in their PBMC. The follow-up survey of MAGE mRNA in PBMC was performed in 12 patients. Seven patients with persistent MAGE-1 and/or MAGE-3 mRNA positive or from negative turned to positive died because of metastasis and/or recurrence. In striking contrast, all four patients with MAGE-1 and/or MAGE-3 mRNA from positive turned to negative and one patient with persistent MAGE-3 transcript negative are alive after last test. Collectively, detection of MAGE transcripts with follow-up survey in PBMC is a feasible and reliable assay for the early prediction of the relapse and prognosis of the HCC patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Mohler T, Hunstein W (1993) Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101: 887–889

    Article  CAS  PubMed  Google Scholar 

  • Cai SL, Chen HS, Wang Y, Zhao HR, Peng JR, Pang XW, Gong SY, Zhu JY, Cong X, Wang Y, Rui JA, Leng XS, Du RY, Chen WF (1999) Expression of MAGE-1 gene in hepatocellular carcinoma. Natl Med J China 79: 668–672

    CAS  Google Scholar 

  • Cai SL, Zhao HT, Leng XS, Cheng JH, Gong SY, Peng JR, Cong X, Wang Y, Rui JA, Hui YZ, Du RY, Chen WF (2000) Melanoma antigen-3 expression in human hepatocellular carcinoma. Chin J Surg 38: 693–696

    CAS  PubMed  Google Scholar 

  • Chen CH, Huang GT, Lee HS, Yang PM, Yan MD, Chen DS, Sheu JC (1999) High frequency of expression of MAGE genes in human hepatocellular carcinoma. Liver 19: 110–114

    Article  PubMed  Google Scholar 

  • Chou HC, Sheu JC, Huang GT, Wang JT, Chen DS (1994) Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology 107: 630–631

    Article  CAS  PubMed  Google Scholar 

  • Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471–477

    Article  CAS  PubMed  Google Scholar 

  • De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360–369

    Article  CAS  PubMed  Google Scholar 

  • Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S (1995) The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72: 155–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R (1994) Albumin messenger RNA as a marker of circulating hepatocytes in hepatocelular carcinoma. Gastroenterology 106: 239–242

    Article  CAS  PubMed  Google Scholar 

  • Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ, Morton DL (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13: 2109–2116

    Article  CAS  PubMed  Google Scholar 

  • Israeli RS, Miller Jr WH, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WDW (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumour cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306–6310

    CAS  PubMed  Google Scholar 

  • Israeli RS, Miller Jr WH, Su SL, Samadi DS, Powell CT, Heston WD, Wise GJ, Fair WR (1995) Sensitive detection of prostatic hematogenous tumour cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 53: (3 Pt 1) 73–77

    Google Scholar 

  • Jiang SY, Shyu RY, Huang MF, Tang HS, Young TH, Roffler SR, Chiou YS, Yeh MY (1997) Detection of alphafetoprotein expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer 75: 928–933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kar S, Carr BI (1995) Detection of liver cells in peripheral blood of patients with advanced hepatocelular carcinoma. Hepatology 21: 403–407

    CAS  PubMed  Google Scholar 

  • Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214–2219

    Article  CAS  PubMed  Google Scholar 

  • Kruger WH, Stockschlader M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Loliger C, Gieseking F, Jonat W, Zander AR (1996) Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18: Suppl 1 S18–S20

    PubMed  Google Scholar 

  • Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, Bismuth H, Debuire B (1997) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 226: 43–50

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liver Cancer Study Group of Japan (1989) TNM classification for hepatocellular carcinoma by Liver Cancer Study Group of Japan. World J Surg 13: 212

  • Lucas S, De Smet, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T (1998) Identification of a new MAGE gene with tumour-specific expression by representational difference analysis. Cancer Res 58: 743–752

    CAS  PubMed  Google Scholar 

  • Lurquin C, De Smet, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T (1997) Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumours of various histological origins. Genomics 46: 397–408

    Article  CAS  PubMed  Google Scholar 

  • Malek L, Jerome N, Herve Z, Abdelmajid S, Corinne V, Giovanna V, Karine P, Monique T, Frederique C, Stanislas P, Dominique F, Bernard L, Christian B, Paterlini PB (1999) Liver resection and needle liver biopsy cause hematogeneous dissemination of liver cells. Hepatology 29: 879–882

    Article  Google Scholar 

  • Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y, Omata M (1994) Detection of alpha-fetoprotein mRNA, an indicator of haematogeous spreading hepatocellular carcinoma, in the circulation: A possiple predictor of metastatic hepatocellular carcinoma. Hepatology 20: 1418–1425

    Article  CAS  PubMed  Google Scholar 

  • Miyajima Y, Horibe K, Fukuda M, Matsumoto K, Numata S, Mori H, Kato K (1996) Sequential detection of tumour cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 77: 1214–1219

    Article  CAS  PubMed  Google Scholar 

  • Miyamoto A, Fujiwara Y, Sakon M, Nagano H, Sugita Y, Kondo M, Eguchi H, Dono K, Umeshita K, Nakamori S, Monden M (2000) Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma. Dig Dis Sci 45: 1376–1382

    Article  CAS  PubMed  Google Scholar 

  • Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akiyoshi T (1996) Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 63: 739–743

    Article  Google Scholar 

  • Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP (1995) Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 92: 4987–4991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Naito H, Kuzumaki N, Uchino J, Kobayashi R, Shikano T, Ishikawa Y, Matsumoto S (1991) Detection of tyrosine hydroxylase mRNA and minimal meuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27: 762–765

    Article  CAS  PubMed  Google Scholar 

  • Negrin RS, Blume KG (1991) The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78: 255–258

    CAS  PubMed  Google Scholar 

  • Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcription and polymerase chain reaction. Lancet 338: 1227–1229

    Article  CAS  PubMed  Google Scholar 

  • Tahara K, Mori M, Sadanaga N, Sakamoto Y, Kitano S, Makuuchi M (1999) Expression of the MAGE gene family in human hepatocellular carcinoma. Cancer 85: 1234–1240

    Article  CAS  PubMed  Google Scholar 

  • van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647

    Article  CAS  PubMed  Google Scholar 

  • Wong IH-N, Leung T, Ho S, Lau WY, Chan M, Johnson PJ (1997) Semiquantitation of circulating hepatocelular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 76: 629–633

    Article  Google Scholar 

  • Yamashita N, Ishibashi H, Hayashida K, Kudo J, Takenaka K, Itoh K, Niho Y (1996) High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Hepatology 24: 1437–1440

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by 973 Program in China, Grant No.: G1999053904; Ludwig Institute for Cancer Research Grant KSP No. 003; Beijing Municipal Government Foundation for Natural Sciences, Grant No.: 7001002.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to X-S Leng or W-F Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mou, DC., Cai, SL., Peng, JR. et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86, 110–116 (2002). https://doi.org/10.1038/sj.bjc.6600016

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bjc.6600016

Keywords

This article is cited by

Search

Quick links